Klinar CRO attended in the International Clinical Trials Day (ICTD) 2021 online conferencec in May

Platform trials, sometimes known as adaptive platform trials, allow a multitude of different treatment options (arms) to be compared with a single control (arm). They enable ineffective arms to be stopped after an interim analysis. To date, they have been used principally in the field of oncology and more recently infectious diseases. They represent the clinical approach selected by the European Commission to find a treatment for COVID-19.

This new trial format raises many questions, changes our approach to conducting clinical trials and testing for appropriate treatments. Through this online conference, we hope to help you answer some of the following questions:

• What are the underlying objectives of a platform trial?
• Which parameters must be considered in the design, statistical plan and data management?
• How should one address regulatory and ethical issues as well as the involvement of patients?
• What types of management, economic and governance concerns may be encountered when we use this trial model?